Tinea Cruris Diagnosis and Treatment Guidelines

Diagnosis

The diagnosis of tinea cruris should be confirmed with potassium hydroxide (KOH) preparation microscopy before initiating treatment whenever possible, according to Praxis Medical Insights 1
Specimens for diagnosis can be collected via scalpel scraping or swab from the active border of the lesion 2
Mounting specimens in 10-30% potassium hydroxide and examining for hyphae and arthroconidia is a recommended diagnostic method 3
Culture on Sabouraud agar is recommended but not always necessary if microscopy is positive and clinical features are typical 3
In high-risk populations or when clinical features strongly suggest tinea cruris, starting treatment immediately is reasonable while awaiting confirmation 1

Topical terbinafine 1% cream applied once daily for 1 week is the first-line treatment for tinea cruris, as recommended by Praxis Medical Insights 4
Butenafine applied twice daily for 2 weeks is an alternative topical option if terbinafine is unavailable or not tolerated 4
Clotrimazole 1% applied twice daily for 4 weeks is another alternative topical option 4
Oral antifungal therapy should be reserved for extensive infections, treatment failures, or immunocompromised patients 2

Addressing predisposing factors such as covering active tinea pedis with socks, completely drying the groin folds after bathing, using separate towels, and cleaning contaminated clothing and personal items can help prevent relapse 4, 2, 1
Avoiding skin-to-skin contact with infected individuals and sharing of personal items can also help prevent recurrence 1

Continuing treatment for at least 1 week after clinical clearing can help prevent relapse 4
Standard treatment duration for tinea cruris is 2 weeks with azoles, but only 1 week with terbinafine 4
If clinical improvement occurs but mycology remains positive, continuing current therapy for an additional 2-4 weeks is recommended 4, 2
Mycological cure, not just clinical response, is the definitive treatment endpoint 2

Topical therapy alone is generally sufficient for localized tinea cruris 2
Griseofulvin is contraindicated in lupus erythematosus, porphyria, and severe liver disease 2